| Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma TE Hutson, ID Davis, JPH Machiels, PL De Souza, S Rottey, B Hong, ... Journal of Clinical Oncology 28 (3), 475-480, 2010 | 354 | 2010 |
| Phosphorylation of human estrogen receptor α at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera D Chen, E Washbrook, N Sarwar, GJ Bates, PE Pace, ... Oncogene 21 (32), 4921-4931, 2002 | 310 | 2002 |
| Rapid modulation of PSMA expression by androgen deprivation: serial 68Ga-PSMA-11 PET in men with hormone-sensitive and castrate-resistant prostate cancer commencing androgen … L Emmett, C Yin, M Crumbaker, G Hruby, A Kneebone, R Epstein, ... Journal of Nuclear Medicine 60 (7), 950-954, 2019 | 179 | 2019 |
| Popularity of less frequent follow up for breast cancer in randomised study: initial findings from the hotline study T Gulliford, M Opomu, E Wilson, I Hanham, R Epstein Bmj 314 (7075), 174, 1997 | 168 | 1997 |
| The CXCL12–CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies RJ Epstein Nature Reviews Cancer 4 (11), 901-909, 2004 | 167 | 2004 |
| Results of a prospective phase 2 pilot trial of 177Lu–PSMA-617 therapy for metastatic castration-resistant prostate cancer including imaging predictors of treatment response … L Emmett, M Crumbaker, B Ho, K Willowson, P Eu, L Ratnayake, ... Clinical genitourinary cancer 17 (1), 15-22, 2019 | 166 | 2019 |
| Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma CH Hsu, TS Yang, C Hsu, HC Toh, RJ Epstein, LT Hsiao, PJ Chen, ZZ Lin, ... British Journal of Cancer 102 (6), 981-986, 2010 | 162 | 2010 |
| Learning from the problems of problem-based learning RJ Epstein BMC Medical Education 4, 1-7, 2004 | 132 | 2004 |
| Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy M Campone, I Bondarenko, S Brincat, Y Hotko, PN Munster, ... Annals of oncology 23 (3), 610-617, 2012 | 127 | 2012 |
| Six authors in search of a citation: villains or victims of the Vancouver convention? RJ Epstein British Medical Journal 306 (6880), 765-767, 1993 | 121 | 1993 |
| Drug-induced DNA damage and tumor chemosensitivity. RJ Epstein Journal of Clinical Oncology 8 (12), 2062-2084, 1990 | 120 | 1990 |
| Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy T Yau, CY Lo, RJ Epstein, AKY Lam, KY Wan, BH Lang Annals of surgical oncology 15, 2500-2505, 2008 | 110 | 2008 |
| Management of advanced hepatocellular carcinoma in the era of targeted therapy T Yau, P Chan, R Epstein, RTP Poon Liver international 29 (1), 10-17, 2009 | 108 | 2009 |
| VEGF signaling inhibitors: more pro-apoptotic than anti-angiogenic RJ Epstein Cancer and Metastasis Reviews 26, 443-452, 2007 | 103 | 2007 |
| Human molecular biology: An introduction to the molecular basis of health and disease R Epstein Cambridge University Press., 2002 | 96 | 2002 |
| Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control K Connolly, P Manders, P Earls, RJ Epstein Cancer treatment reviews 40 (2), 205-214, 2014 | 95 | 2014 |
| Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer H Wong, S Lau, T Yau, P Cheung, RJ Epstein British journal of cancer 102 (9), 1391-1396, 2010 | 89 | 2010 |
| Methicillin-resistant commensal staphylococci in healthy dogs as a potential zoonotic reservoir for community-acquired antibiotic resistance CR Epstein, WC Yam, JSM Peiris, RJ Epstein Infection, Genetics and Evolution 9 (2), 283-285, 2009 | 82 | 2009 |
| Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction GC HUANG, X OUYANG, RJ EPSTEIN Biochemical Journal 331 (1), 113-119, 1998 | 79 | 1998 |
| Evolution of systemic therapy of advanced hepatocellular carcinoma T Yau, P Chan, R Epstein, RT Poon World journal of gastroenterology: WJG 14 (42), 6437, 2008 | 78 | 2008 |
